Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab and Aflibercept in DME
NCT02646670Phase 4Completed
- Sponsor
- Instituto de Olhos de Goiânia
- Start
- Jul 2015
- Primary completion
- Oct 2015
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 4 trial of ranibizumab, aflibercept in diabetic macular edema (DME), sponsored by Instituto de Olhos de Goiânia. Started Jul 2015; status: completed.
02
Drugs
ranibizumabaflibercept
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02646670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02646670.